GENTAUR Contact Gentaur

Up

GENTAUR Survey

GENTAUR EUROPE

+32 1658 9045
+32 1650 9045

BELGIUM1

tel +32 2 732 5688
fax +32 2 732 4414
info@gentaur.com
Av. de l' Armée 68
B-1040 Brussels

France

tel 01 43 25 01 50
fax 01 43 25 01 60
9, rue Lagrange
75005 Paris

Italy

tel 02 36 00 65 93
fax 02 36 00 65 94
20135 Milano

Germany

tel +32 16 58 90 45
fax +32 16 50 90 45
Forckenbeckstraße 6
D-52074 Aachen

Japan

tel +81 78 386 0860
fax +81 78 306 0296
Minaatojimaminami-manchi
Chuo-ku, Kobe
065-0047


OSCAR Cytokeratin
Clone: OSCAR

Signet’s Cytokeratin (keratin) antibody clone OSCAR demonstrates a broad spectrum of cytokeratin reactivity in Western blots. In normal tissues, OSCAR is reactive with most epithelial types tested including; bile ducts and hepatocytes in liver, bladder epithelium, breast ducts, bronchial epithelium, endometrium, follicular dendritic cells of lymph node and tonsil, intestinal epithelium of: stomach, duodenum, ileum, colon, rectum, pancreas, ovarian epithelium, pancreatic acini, pituitary acini, pneumocytes, prostate, thyroid, skin: positive on the basal layer and negative on the superficial layers of squamous epithelium, positive on apocrine and sweat glands. In tumors, OSCAR is reactive with most carcinomas including; breast CA, TCC, RCC, lung adeno CA, lung small cell CA, lung squamous cell CA, endometrial CA, prostate CA, ovarian CA, HCC, colorectal CA, stomach CA, thyroid CA. It is negative in certain normal tissues including brain, lymphocytes and all cells of hematolymphoid origin, muscle, brain, nerves, endothelium and in certain tumors including melanoma, sarcoma, lymphoma, PNET / Ewings, GIST.
Master Cat. No. 465 Cat. No. 465 Clone: OSCAR

 

Catalog # Format Quantity Price
465-01   Concentrate   1ml   283.50  
       
465-16   Level 1 predilute   6ml   185.40  
       
465-26   Level 2 predilute   6ml   154.80  

Home Up

send mail to webmaster@gentaur.com with questions or comments about this web site.
Copyright © 2008 Gentaur Molecular Products
Site powered by Acid Dragon (AC)
Last modified: 05/19/16